Innoviva Inc (INVA)
15.98
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
15.99
+0.01
(+0.06%)
After-Hours: 20:00
Innoviva Cash from Operations (Quarterly): 37.05M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 37.05M |
| December 31, 2023 | 33.26M |
| September 30, 2023 | 43.94M |
| June 30, 2023 | 38.18M |
| March 31, 2023 | 25.68M |
| December 31, 2022 | 8.899M |
| September 30, 2022 | 15.69M |
| June 30, 2022 | 79.04M |
| March 31, 2022 | 98.10M |
| December 31, 2021 | 98.38M |
| September 30, 2021 | 96.71M |
| June 30, 2021 | 84.61M |
| March 31, 2021 | 84.11M |
| December 31, 2020 | 85.28M |
| September 30, 2020 | 74.56M |
| June 30, 2020 | 79.79M |
| March 31, 2020 | 73.48M |
| December 31, 2019 | 66.90M |
| September 30, 2019 | 57.40M |
| June 30, 2019 | 56.50M |
| March 31, 2019 | 76.66M |
| December 31, 2018 | 61.78M |
| September 30, 2018 | 60.12M |
| June 30, 2018 | 51.72M |
| March 31, 2018 | 49.91M |
| Date | Value |
|---|---|
| December 31, 2017 | 47.86M |
| September 30, 2017 | 43.49M |
| June 30, 2017 | 22.64M |
| March 31, 2017 | 27.76M |
| December 31, 2016 | 21.09M |
| September 30, 2016 | 20.19M |
| June 30, 2016 | 12.46M |
| March 31, 2016 | 7.25M |
| December 31, 2015 | 6.917M |
| September 30, 2015 | 2.656M |
| June 30, 2015 | 2.174M |
| March 31, 2015 | -1.616M |
| December 31, 2014 | -4.61M |
| September 30, 2014 | -21.07M |
| June 30, 2014 | -54.40M |
| March 31, 2014 | -50.64M |
| December 31, 2013 | -39.97M |
| September 30, 2013 | -41.31M |
| June 30, 2013 | -16.69M |
| March 31, 2013 | -31.63M |
| December 31, 2012 | -24.25M |
| September 30, 2012 | -27.56M |
| June 30, 2012 | -34.37M |
| March 31, 2012 | -41.33M |
| December 31, 2011 | -25.36M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
8.899M
Minimum
Dec 2022
98.38M
Maximum
Dec 2021
61.88M
Average
70.19M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -4.881M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -43.04M |
| Cash from Financing (Quarterly) | -9.165M |
| Free Cash Flow | 152.43M |
| Free Cash Flow Per Share (Quarterly) | 0.4383 |
| Free Cash Flow to Equity (Quarterly) | 36.52M |
| Free Cash Flow to Firm (Quarterly) | 38.22M |
| Free Cash Flow Yield | 11.88% |